Related Experiment Video
Updated: Jul 7, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Perceived Stigma in Patients with Autoimmune Hepatitis
Jessica P Naftaly1,2, Estée C H Feldman3, Rachel N Greenley4
1Department of Internal Medicine-Gastroenterology, Michigan Medicine, University of Michigan, 1500 E. Medical Center Drive, Floor 3, Reception D, Ann Arbor, MI, 48109, USA. jnaftaly@med.umich.edu.
Patients with autoimmune hepatitis (AIH) experience significant perceived stigma (PS), impacting their health. Addressing PS through provider screening and psychologists can improve outcomes for AIH patients.
Area of Science:
- Hepatology
- Psychology
- Public Health
Background:
- Perceived stigma (PS) negatively affects psychosocial and disease outcomes in chronic liver diseases (CLD).
- Autoimmune hepatitis (AIH) patients may face PS due to misconceptions about disease origin.
- Understanding PS prevalence and correlates in AIH is crucial for patient care.
Purpose of the Study:
- To determine the frequency of PS in patients diagnosed with AIH.
- To compare PS rates between AIH, primary biliary cholangitis (PBC), and general CLD populations.
- To identify demographic factors associated with PS in AIH patients.
Main Methods:
- Online questionnaires were administered to 262 adult AIH patients (95% female, mean age 51.53 years).
- Data collected included demographics, disease information, and perceived stigma levels.
- Statistical analyses examined PS frequency, comparative rates, and demographic correlations.
Main Results:
- 54-68% of AIH patients reported experiencing PS, often involving selective disclosure, non-disclosure, or hiding their diagnosis.
- PS rates were higher in AIH patients compared to PBC patients.
- PS was less prevalent in AIH patients than in patients with various other CLDs. Age showed an inverse relationship with PS.
Conclusions:
- A significant proportion of AIH patients experience PS, necessitating targeted interventions.
- Provider screening for PS and the integration of clinical health psychologists are recommended for AIH patient support.
- These interventions can help identify and manage PS, potentially improving psychosocial and disease outcomes.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

